David Jungpa Lee

Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas

Hee‐Yeon Cho, Weijun Wang, Niyati Jhaveri et al. · Molecular Cancer Therapeutics · 2012 · 87 citations

Neuro-oncology, Oncogenic Agent, Medicine +14

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Annie Cowan, Federico Ferrari, Samuel S. Freeman et al. · The Lancet Haematology · 2023 · 72 citations · Full text

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector

David Jungpa Lee, Nagalingeswaran Kumarasamy, Stephen Resch et al. · PLoS ONE · 2019 · 68 citations · Full text

NEO212, Temozolomide Conjugated to Perillyl Alcohol, Is a Novel Drug for Effective Treatment of a Broad Range of Temozolomide-Resistant Gliomas

Hee‐Yeon Cho, Weijun Wang, Niyati Jhaveri et al. · Molecular Cancer Therapeutics · 2014 · 61 citations · Full text

Chemoprevention Strategy, Pathology, Temozolomide-resistant Gliomas +17

Open lung biopsy in pediatric patients on extracorporeal membrane oxygenation

Sheldon J. Bond, David Jungpa Lee, Dan L. Stewart et al. · Journal of Pediatric Surgery · 1996 · 28 citations

Pulmonary Care, Pediatric Lung Disease, Open Lung Biopsy +2